Coming up: Oral GLP1s – What GPs need to know

4 minute read


Options for the medical management of obesity are set to expand with the expected introduction of two new oral GLP-1 receptor agonists into the Australian market.


This content is for AHPRA registered professionals only.
Join Now

End of content

No more pages to load

Log In Register ×